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Transferrin (TF) and lactoferrin (LF) are probably the major sources of iron (Fe) for Neisseria gonorrhoeae
in vivo. We isolated mutants of N. gonorrhoeae FAl9 that were unable to grow with Fe bound to either TF
(TF-) or LF (LF-) or to both TF and LF ([TF LF]-). The amount of Fe internalized by each of the mutants
was reduced to background levels from the relevant iron source(s). The wild-type parent strain exhibited
saturable specific binding of TF and LF; receptor activity was induced by Fe starvation. The TF--specific or
LF--specific mutants were almost completely lacking in receptor activity for TF or LF, respectively, whereas
the [TF LF]- mutants bound both TF and LF as well as the wild-type strain. AU mutants utilized citrate and
heme normally as Fe sources. These results demonstrate that ability to bind TF or LF is essential for gonococci
to scavenge appreciable amounts of Fe from these sources in vitro. In addition, the TF and LF Fe acquisition
pathways are linked by the mutual use of a nonreceptor gene product that is essential to Fe scavenging from
both of these sources; this gene product is not required for Fe acquisition from other sources.
Iron (Fe) is an essential nutrient for the growth of almost
all microorganisms. Most bacteria produce siderophores
(low-molecular-weight iron chelators) to compete with exist-
ing Fe-binding compounds, or to solubilize Fe, which forms
highly insoluble complexes in aerobic aqueous environments
(18-20). These bacteria subsequently acquire the sidero-
phore-bound Fe through a receptor-mediated pathway. Most
siderophore-producing bacteria are able to exist both in
inanimate environments in which all Fe is in the form of
insoluble complexes and in environments in which Fe is
bound to soluble Fe chelators. Neisseria gonorrhoeae is
relatively unusual in its apparent absence of siderophore
production (22, 36, 37) and in that it is found naturally only
in humans, an environment in which Fe is sequestered by a
variety of soluble Fe-carrying glycoproteins or heme com-
pounds. Perhaps for these reasons gonococci have evolved
mechanisms for obtaining Fe which are quite different from
those utilized by siderophore-producing bacteria.
The Fe sources available to gonococci vary depending on
the site of infection. Lactoferrin (LF) is probably the major
Fe source during localized infections on the mucosal sur-
faces of the urogenital tract, rectum, pharynx, and eye (3,
13), whereas transferrin (TF) is probably the major Fe
source during invasive infections of the bloodstream, syn-
ovial fluid, and cerebrospinal fluid (35). All gonococcal
strains utilize TF as an Fe source (16) and most gonococcal
strains are able to utilize LF, heme, hemin, hemoglobin, and
certain hydroxamate siderophores produced by other bacte-
ria (15, 16, 36, 38). However, because sources other than TF
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and LF either are utilized inefficiently or are not readily
available to the gonococcus during an infection (7, 16, 17, 36,
37), they are believed to be minor Fe sources.
The mechanisms used by gonococci to scavenge Fe from
TF or LF are not completely understood. Both TF and LF
are only partially Fe saturated in vivo and bind Fe with high
affinity, yet gonococci are able to remove Fe very efficiently
from these proteins. The mechanisms are energy requiring,
and full expression of the Fe uptake system requires prior
growth under Fe starvation conditions (14). The ability to
acquire Fe from TF and LF saturates at about 1 1±M for both
proteins and requires direct contact between the protein and
the gonococcal cell surface (14), suggesting that gonococci
may possess saturable receptors for both TF and LF. The
removal of Fe from TF or LF does not appear to involve
internalization of the receptor-ligand complex (14).
In these respects, the gonococcus closely resembles the
meningococcus, another non-siderophore-producing organ-
ism (1, 36). Saturable and specific receptors for both TF and
LF were described recently in the meningococcus (26, 27,
33), and the TF receptor was shown to be important to Fe
scavenging (33). The biochemical identities of the meningo-
coccal TF and LF receptors and the functional importance of
the LF receptor remain unclear (26-28, 33). Similar recep-
tors have been suggested for the gonococcus (11); however,
the existence of a gonococcal TF or LF receptor has not
been definitively demonstrated or characterized. Receptors
for binding TF or LF have also been suggested for Hae-
mophilus influenzae, Trichomonas vaginalis, Bordetella per-
tussis, and Mycoplasma pneumoniae (23-25, 32), each of
which is found naturally only in humans and none of which
is known to produce siderophores.
In this communication we provide genetic and biochemi-
cal evidence for specific gonococcal receptors for both TF
and LF, and we demonstrate the importance of these recep-
tors to Fe scavenging.
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TABLE 1. N. gonorrhoeae strains used in this study
Strain Relevant Relevant Source or method ofgenotypea phenotype construction
FA19 Prototroph LF+ TF+ Clinical isolate (15)
FA248 lrf-2 LF- F62 derivative (2)
FA1012 lrf-3 LF- Clinical isolate
FA1092 1ff-5 LF- Clinical isolate
FA1O9S lrf-6 LF- Clinical isolate
FA3000 lrf4 LF- Clinical isolate
FA3002 Irf-7 LF- Clinical isolate
FA6246 lrf-2 LF- Rif A transformant of FA248
StrT
FA6303 tlu-1 [LF TF]- tlu-1 mutation > FA19'
FA6338 trf-I TF- trf-J mutation FA19b
FA6342 trf-3 TF- trf-3 mutation FA19b
FA6353 Irf-J LF- Irf-J mutation FA19b
FA6355 lrf-I trf-I LF-, TF- trf-lmutation FA6353C
FA6356 trf-2 TF- trf-2 mutation - FA19b
FA6366 trf-S TF- trf-S mutation - FA19b
FA6367 trf4 TF- tr4 mutation FA19b
FA6370 tlu-2 [LF TF]- tlu-2 mutation FA19b
FA6378 tlu-3 [LF TF]- tlu-3 mutation > FA19b
FA6381 tlu4 [LF TF]- tlu4 mutation FA19b
FA6382 tlu-S [LF TF]- tlu-S mutation - FA19b
FA6411 trf-l lrf-2 LF- TF- trf-i mutation > FA248C
a Irf, LF receptor function; tr, TF receptor function; tlu, TF, LF utiliza-
tion.
b Ethyl methanesulfonate mutants of FA19 were isolated by streptonigrin
enrichment. The mutations were then transferred back into FA19 by trans-
formation, selecting for a Rif' donor marker and scoring for inability to use
either LF or TF, as described in Materials and Methods.
c DNA isolated from Strr derivative of FA6338.
MATERIALS AND METHODS
Bacterial strains and media. All strains used in this study
are described in Table 1. Gonococci were routinely main-
tained on GCB agar (Difco Laboratories, Detroit, Mich.),
containing 1% Kelloggs supplement I and 0.1% Kelloggs
supplement 11 (9). Cultures were incubated at 37°C with a 5%
CO2 atmosphere. Fe uptake experiments and TF- or LF-
binding experiments utilized gonococci grown on a chemi-
cally defined Fe-depleted medium (CDM) described previ-
ously (36). The concentration of Fe remaining in Fe-depleted
CDM was s0.1 ,uM as determined by atomic absorption
spectroscopy. Glassware was acid washed to remove Fe, as
described previously (16). Growth in CDM broth was mon-
itored by optical density, using a Klett-Sumerson colorime-
ter with a green filter. CDM-agar plates contained 1 to 1.5%
sterile agar or 0.75% sterile agarose (Bethesda Research
Laboratories, Gaithersburg, Md.) and 0.5 to 1% sterile
potato starch (Sigma Chemical Co., St. Louis, Mo.). Agar-
ose or purified agar was prepared by the procedure described
by Catlin (4). CDM-O agar plates or broth were not supple-
mented with Fe, but agar plates contained approximately 2
,uM Fe due to Fe present in the agar (16). CDM+FE plates
and broth were supplemented with 50 ,uM Fe(NO3)3. The
CDM+TF and CDM+LF plates were supplemented with 2
to 5 ,uM apo-TF or apo-LF, respectively, which resulted in
approximately 20 to 50% Fe saturation of TF or LF due to
the residual Fe present in the agar. For designated experi-
ments, the CDM also contained 25 ,uM desferoxamine me-
sylate (Desferal; Ciba Pharmaceutical Co., Summit, N.J.) to
chelate any remaining free Fe.
Fe sources. Human TF (Sigma) was at least 98% pure and
significantly Fe-free according to the supplier and as verified
by sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis. Human LF (a gift of S. V. Pizzo, Duke University
Medical Center) was approximately 95% pure as determined
by sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis and was relatively Fe-free. Human LF was also obtained
from U.S. Biochemical Corp., Cleveland, Ohio, and was
>98% pure according to the supplier. For the Fe uptake
experiments, TF and LF were Fe loaded with "FeCl3 (New
England Nuclear, Boston, Mass.) as described previously
(14); this resulted in 15 and 27% Fe saturation of TF and LF,
respectively, as determined by the Ferrozine assay for Fe
(31). Ferric citrate complexes were prepared by adding a
10-fold molar excess of sodium citrate to "FeCl3. For the
liquid phase binding experiments, TF was 100% saturated
with Fe(NO3)3 and was labeled with [1251I]Na (Amersham
Corp., Arlington Heights, Ill.), using the lodobead method
described previously (33). Iodobeads were purchased from
Pierce Chemical Co., Rockford, Ill. The quality of the
[1251I]TF was verified both by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and by its ability to donate Fe
normally to growing gonococci, using methods described
previously (33).
Mutagenesis and isolation of mutants. The procedure for
isolating Fe uptake mutants was a modification of one used
previously to isolate similar mutants of N. meningitidis (5).
Nonpiliated gonococci were scraped from overnight growth
on CDM+Fe plates, suspended in CDM+Fe broth, and
grown into log phase, when they were diluted back to 108
CFU/ml in CDM-O. Ethyl methanesulfonate (Sigma) was
added to a concentration of 1%, and the cells were incubated
for 20 to 30 minutes with shaking, resulting in an 80 to 95%
decrease in viability as compared with untreated cells.
Following incubation, the cells were washed three times by
centrifugation at room temperature and suspended in an
equal volume of CDM plus 5 p.M Fe(NO3)3. The mutagen-
ized cells were incubated overnight at 37°C in a still culture,
washed once, suspended into CDM containing 5 ,uM 25%
Fe-saturated TF or LF, and incubated at 37°C in a 5% CO2
shaking incubator for 4 to 5 h. Streptonigrin (M. Suffness,
National Cancer Institute, Bethesda, Md.) was added to the
culture at 0.2- to 0.6-,ug/ml final concentration, and the
culture was incubated at 37°C in a 5% CO2 shaking incubator
for 2 h, which resulted in 0.01 to 0.0001% survivorship. The
cells were then washed three times by centrifugation, sus-
pended in fresh CDM, and plated onto GCB agar plates.
Survivors were scored for ability to grow with TF, LF, or
Fe(NO3)3 by transferring the colonies to CDM agar plates
containing one of these Fe sources. Mutants unable to use
either TF or LF were tested for ability to grow on CDM
plates containing heme, hemoglobin, or Fe citrate.
Genetic procedures. To construct an isogenic set of mu-
tants, mutations were transformed back into FA19 by con-
gression, using the procedure described previously (2).
Transformation crosses were then performed between these
transformants to determine relative linkage between various
mutations. Spontaneous drug-resistant mutants were iso-
lated for representative Fe uptake mutants on GCB agar
plates containing S p.g of rifampin (Rif), 5 ,ug of naladixic acid
(Nal), or 100 ,ug of streptomycin (Str) per ml; these Rif7,
Nalr, or Strr derivatives of the Fe uptake mutants were used
to prepare transforming DNA. Frequencies of transforma-
tion for the unlinked drug resistance marker served as an
internal control for the quality of the donor DNA. To control
for differences in competency, recipients were transformed
with FA19 DNA. This allowed calculation of a recombina-
tion index (RI) (8, 10). For example, the RI in a transfor-
mation cross between two TF- mutants = (TF+ transfor-
mants using mutant DNA/drugr transformants using mutant
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DNA) x (drugr transformants using FA19 DNA/TF+ trans-
formants using FA19 DNA).
Transforming DNA was isolated by suspending gonococci
in 10 M Tris-1 mM EDTA (TE), pH 8.0, and adding of
sodium sarcosinate to a final concentration of 0.5% to effect
cell lysis. This crude DNA was diluted 1:500 in TE to give a
final concentration of sodium sarcocinate of 0.001%; this
concentration did not affect the viability of the competent
cells (29). In certain experiments, transforming DNA was
isolated by the procedure described by Marmur (12). Com-
petent cells were obtained by growing piliated gonococci in
CDM-O broth until late log phase and diluting the cells to 108
CFU/ml. Transformation procedures followed the protocols
described previously (2). TF+ or LF+ transformants were
selected on CDM agar plates supplemented with Desferal
and 25% saturated 2.5 ,uM TF or LF, respectively. Drug-
resistant transformants were selected on GCB agar plates
overlaid with the appropriate antibiotic after allowing 5 h for
phenotypic expression of the introduced marker (30).
5sFe uptake. The Fe uptake protocol was adapted from
methods described recently (5, 14). Cells were grown over-
night on CDM+Fe plates, suspended in CDM-O broth at an
optical density of 15 to 20 Klett units, and incubated with
shaking at 37°C in a 5% CO2 atmosphere to induce Fe
starvation. Fe-starved cells were harvested during late ex-
ponential phase and diluted 1:1 in fresh CDM-O or CDM-O
containing 40 mM potassium cyanide (KCN). During a
15-min incubation at 37°C, viable counts were determined.
Cells were then diluted 1:1 in CDM containing partially
5Fe-saturated 5 F.M TF, LF, or citrate. Duplicate samples
were removed after 10 and 30 min of incubation at 37°C, and
55Fe uptake was determined (14).
Equilibrium TF-binding assay. Specific binding of TF to
gonococci used a protocol similar to that described for the
meningococcus (33). Briefly, iron-replete cells taken from
overnight growth on GCB agar plates were suspended in
CDM-O broth to an optical density of 20 Klett units and were
incubated at 37°C in 5% CO2 with shaking to induce Fe
starvation. After 3.5 mass doublings (with back-dilution after
the second doubling), cells were pelleted and suspended in a
1/50 volume of CDM plus 1% bovine serum albumin. The
suspensions contained 0, 0.25, 0.5, 1.0, 2.0, or 5.0 ,uM
[1251I]TF in the presence and absence of a 100-fold excess of
cold TF. After 20 min of incubation at 25°C, the cells were
washed twice by pelleting and suspending in equal volumes
of CDM-O plus 1% bovine serum albumin. Cell-associated
radioactivity was determined in a Packard Minoxi gamma (y)
Auto 5000 series counter. Specific binding was calculated as
the amount of [125I]TF bound minus the amount of [251I]TF
bound in the presence of a 100-fold excess of cold TF.
Dot blot TF- and LF-binding assay, using ligand dilutions.
Cells were grown overnight on CDM-O plates and sus-
pended in CDM-O broth. Approximately i07 CFU were
applied to each well of one row of a Miniblot apparatus
(Millipore Corp., W. Bedford, Mass.) and were filtered onto
nitrocellulose; different strains were applied to separate
rows. The filter was dried, blocked in blotto (0.5% skim
milk, 50 mM Tris [pH 7.5], 150 mM NaCl), and cut into
vertical strips. The nitrocellulose strips were incubated in
blotto containing serial dilutions of TF- or LF-horseradish
peroxidase (HRP) conjugate (Jackson ImmunoResearch,
Westgrove, Pa.). The remainder of the procedure was as
described by Schryvers and Morris (27), with the following
modifications: during the ligand-binding step, cells were
incubated at 25°C (instead of 37°C), and the blocking solution
for the LF-HRP contained 500 mM NaCl (instead of 150
mM).
Dot blot TF-binding assay, using cell dilutions. Cells were
grown overnight on CDM-O and CDM+Fe plates. The cells
were suspended in CDM-O, and a suspension of approxi-
mately 108 CFU was applied to the first column of the
Miniblot apparatus, one strain per row. Each successive
column contained a 1:1 dilution of the cells in the previous
column. The cells were filtered onto the nitrocellulose. The
filters were dried, blocked as above, and incubated with 500
ng of TF-HRP per ml. The dot blots were developed as
above. This assay allowed a more sensitive analysis of ligand
binding to the Fe-sufficient cells (with reduced receptor
expression) and to the TF receptor mutants (with apparent
reduction in receptor affinity).
RESULTS
Isolation of TF and LF utilization mutants. By use of ethyl
methanesulfonate mutagenesis followed by streptonigrin en-
richment (5), we isolated mutants of FA19 (TF+ LF+) that
were unable to grow with TF or LF or both as Fe source.
Mutants occurred at a frequency of 0.1 to 1% among
survivors of streptonigrin enrichment. In eight experiments,
a total of 105 Fe utilization mutants were isolated. These
mutants fell into three phenotypic classes: 55 were unable to
use TF, but could use LF (TF-); 2 were unable to use LF,
but could use TF (LF-); and 48 were unable to use either TF
or LF [TF LF]-. Each of the tested mutants (FA6303,
FA6338, FA6342, FA6353, FA6356, FA6366, and FA6367)
grew normally on CDM plates supplemented with heme,
hemoglobin, or Fe-citrate. Each tested mutant was relatively
stable, reverting to TF+, LF+, or [TF LF]+ at a frequency of
10-6 or less. Representative mutations from each of the
three phenotypic classes were transformed back into the
parental strain FA19 by congression to help remove un-
linked, unrelated mutations resulting from the chemical
mutagenesis. Most of the mutants we discuss are the result
of back-transformations; all strains used in this study are
described in Table 1.
Mapping of the mutational sites. Loci for the TF-, LF-,
and [TF LF]- phenotypes were designated trf (TF receptor
function), Irf (LF receptor function), and tlu (TF, LF utili-
zation), respectively. Transformation experiments were per-
formed to compare relative linkage between representative
trf, lrf, and tlu mutations. Since transformation is intrinsi-
cally variable, the linkage relationships were expressed as an
RI; an RI of <1.0 generally denotes linkage between markers
(8). Analysis-of-variance methods were used to determine
whether RIs were significantly <1.0. Statistical analysis was
complex, and details are included in the Appendix. RIs
calculated from an analysis of variance that included com-
ponents for recipient and donor are displayed in Table 2 with
corresponding observed ratios. The recipient strain (Rif) in
initial recombination experiments was FA6355, a con-
structed double mutant (trf-1 Irf-1). Donor DNA (Rif) was
obtained from wild-type strain FA19 as well as mutant
strains FA1012 (lrf-3), FA6342 (trf-3), and FA6378 (tlu-7).
Transformation of FA6355 with donor DNA from wild-type
strain FA19 produced almost equal numbers of TF+ and
LF+ transformants (Table 2). However, donor DNA from
FA6342 (trf-3) produced many fewer TF+ transformants,
and donor DNA from FA1012 (lrf-3) produced many fewer
LF+ transformants, as compared with other selected mark-
ers and as compared with FA19. These results indicated
linkage of trf-J to trf-3 and Irf-l to lrf-3. Next, with FA6355
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LF+ TF+ Rif Observed' Estimatedd Observed Estimated
FA19 5.9 x 104 5.6 x 1io 3.4 x 10o 1.0 1.0 1.0 1.0
FA1012 Irf-3 2.8 x 103 7.1 x 104 3.0 x 10i 0.05 0.06 1.44 1.12
(0.01, 0.24 (0.26, 4.83)
FA6342 trf-3 1.5 x 10' 1.1 x 1o4 5.0 x io4 1.73 1.28 0.13 0.09
(0.30, 5.52) (0.02, 0.40)
FA6378 tlu-3 1.6 x 105 1.2 x 105 5.0 x 104 1.85 1.34 1.46 1.05
(0.31, 5.76) (0.24, 4.52)
a Recipient strain, FA6355 lr-) tf-l.
b RIs of <1.0 suggest linkage of markers, whereas RIs of .1.0 suggest nonlinkage of markers; see text for explanation.
c Values for wild-type FA19 DNA were normalized tol.0, for purpose of comparison to the other strains. The RIs for FA1012, FA6342, and FA6378 are the
ratio of the observed RI to the RI for FA19. Values are the means of two experiments.
d Estimated RI values were calculated based on analysis of variance. 95% confidence intervals are given in parentheses.
(trf-1 lrf-1) as a recipient strain, donor DNA from FA6342
(trf-3) and FA1012 (lrf-3) produced as many LF+ and TF+
transformants, respectively (RIs, >1.0), as did the parental
strain FA19. This suggested that the trf-3 and Irf-3 muta-
tional sites were unlinked. Donor DNA from FA6378 (tlu-3)
produced as many TF+ and LF+ transformants of FA6355
(trf-1 1rf-1) as did the parental strain FA19. This indicated
that the tiu-3 mutation that produced the [TF LF]- pheno-
type was unlinked to either trf-l or lrf-1. These conclusions
were..verified with analysis-of-variance methods.
TF mutants are linked. DNA from crude lysates of 33
originally isolated TF- mutants were used to transform a
competent TF mutant, FA6338 (trf-1). In all cases the RIls
were <0.5 (data not shown), suggesting that the mutational
sites of all TF- mutants were linked genetically.
TF strains FA6338, FA6342, FA6356, FA6366, and
FA6367 were used in reciprocal transformations, with each
strain being both aDNA donor and a recipient for each of the
other strains. The resulting RIs from an analysis of variance
that included components for recipient, donor, day of study,
media, recipient x -media, and donor x media (see Appen-
dix) ranged from 0.04 to 0.59 (Table 3). Our main objective
was to obtain a linear ordering (or map) of these mutations
based on the Rls in Table 3, and taking into account the
extent of their random variation and donor-versus-recipient
symmetry of Ills. Analysis along these lines suggested a
linear order of tif-2, trf-3, tr-i, trf4, and tn-S, with trf-2
being further away from the others. Detailed statistical
modeling and analysis are considered in the Appendix.
LF- mutations are linked. Although only two LF- mutants
were isolated by streptonigrn enrichment, naturally occur-
ring LF- mutants have been isolated (15) and several were
included in this study. Transformation of mutant FA6353
(lrf-1) with DNA from each ofthe other LF- mutants yielded
RIs varying from 0.07 to 0.57 (Table 4 and data not shown).
Also shown in Table 4 are RIs calculated from an analysis of
variance that included components for recipient, donor, and
day. Similarly low RIs were obtained with LF- strains
FA1012, FA3000, and FA6411 as recipients (data not
shown). Statistical analysis suggested that all but one of
these mutants were linked (see Appendix). The unlinked
LF- mutation (lrf-2) was a naturally occurring mutation,
found in a derivative of gonococcal strain F62. Thus, we
found two genetically distinct classes of LF- mutations, all
but one of which were clustered in a single linkage group.
[TF LF]- mutations are linked. Transformation of a [TF
LFf- recipient strain (FA6303) with DNA from FA19 (TF+
LF+) yielded [TF LF]+ transformants, but never TF+ LF-
or TF- LF+ transformants. Furthermore, reversion studies
with mutant FA6303 showed that the [TF LF]- phenotype
reverted simultaneously to [TF LF]+ at a frequency of about
10-6 (data not shown). Transformation of competent mutant
FA6303 with DNA from 28 other [TF LF]- mutants pro-
duced Rls that varied from 0.1 to 0.5, indicating apparent
linkage of the [TF LF]- mutations (data not shown). The
linkage was confirmed by using isogenic strains FA6303,
FA6370, FA6378, FA6381, and FA6382 in reciprocal trans-
TABLE 3. RIs of reciprocal transformations between TF- mutations based on ANOVA estimation
RI (no. of expt)
Recipient
strain FA6356 FA6342 FA6338 FA6367 FA6366
trf-2a trf-3 trf4- trf4 trf-5
FA6356 trf-2 0.07 (4) 0.08 (4) 0.14 (4) 0.24 (4)
[0.04, 0.13]b [0.04, 0.14] [0.08, 0.26] [0.13, 0.44]
FA6342 trf-3 0.04 (4) 0.14 (4) 0.14 (4) 0.33 (4)
(0.02, 0.07] [0.07, 0.25] [0.08, 0.26] [0.18, 0.62]
FA6338 trf-1 0.05 (7) 0.09 (6) 0.24 (5) 0.42 (6)
[0.03, 0.07] [0.05, 0.14] [0.14, 0.40] [0.26, 0.69]
FA6367 trf-4 0.13 (4) 0.41 (4) 0.59 (3) 0.13 (3)
[0.07, 0.25] [0.22, 0.78] [0.30, 1.19] [0.06, 0.25]
FA6366 trf-5 0.09 (4) 0.26 (5) 0.36 (6) 0.21 (5)
[0.05, 0.16] [0.15, 0.44] [0.21, 0.59] [0.12, 0.35]
a Donor strain.
b 95%confidence intervals are given in brackets.
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(no. of expt)b Estimated'
FA1012 (Irf-3) 0.09 (5) 0.05
(0.02, 0.15)
FA1092 (Irf-5) 0.10 (3) 0.06
(0.02, 0.20)
FA1095 (lrf-6) 0.2 (3) 0.08
(0.02, 0.30)
FA3000 (lrf4) 0.07 (4) 0.06
(0.02, 0.19)
FA3002 (Irf-7) 0.15 (5) 0.10
(0.03, 0.3)
FA6246 (Irf-2) 0.57 (5) 0.40
(0.13, 1.19)
a Recipient strain, FA6353 (lfr-J).
b Values were determined from LF+ and Rif' transformants.
c See Table 2, footnote d.
formations. The RIs were identical regardless of whether TF
or LF was used to select transformants.
55Fe uptake by mutants. Fe-starved cells of FA6367 (TF-)
demonstrated no net uptake of TF-bound 55Fe as compared
with Fe-starved cells of wild-type strain FA19 (Fig. 1).
However, Fe-starved FA6367 was able to acquire normal
levels of 55Fe from both LF and citrate (Fig. 1). Each of the
other tested TF- mutants (FA6338, FA6342, FA6356, and
FA6366) gave essentially identical results (data not shown).
Fe-starved cells of FA6353 (LF-) demonstrated insignificant
(<1%) uptake of LF-bound 55Fe as compared with FA19,
but retained wild-type ability to internalize both TF- and
citrate-bound 55Fe (Fig. 1). Fe-starved cells of [TF LF]-
mutant FA6303 were reduced dramatically in the ability to
internalize both TF- and LF-bound 55Fe, but retained normal
ability to take up citrate-bound 55Fe (Fig. 1). Thus, each
mutant class demonstrated nearly total loss of 55Fe uptake
for either TF or LF, or both, in keeping with the results of
growth assays; the mutations had no effect on Fe acquisition
from other Fe sources.
Identification of a gonococcal TF receptor. In an equilib-


















FIG. 2. Binding of [125I]TF by Fe-starved cells of wild-type
strain FA19 (O), Fe-sufficient cells of FA19 (A), and Fe-starved
cells of TF- mutant FA6366 (0). Values represent the mean of three
or more experiments + 1 standard deviation.
strated saturable specific binding of [125I]TF. The level ofTF
receptor activity was dramatically reduced during Fe-replete
growth conditions (Fig. 2). Scatchard analysis of the data in
Fig. 2 revealed a copy number of approximately 2,800
receptors per CFU, with an apparent affinity (Kd) of 0.46 ,uM
(data not shown). Neither mouse TF nor human LF com-
peted with the binding of human TF (data not shown). In
contrast, apo-TF appeared to compete almost as effectively
as Fe-TF: the difference in competitive binding between
apo-TF and Fe-TF was not statistically significant after four
experiments (Fig. 3). In a solid-phase (dot blot), TF-binding
assay, human LF and mouse TF did not compete with the
Fe-TF-HRP conjugate, whereas both apo-TF and Fe-TF did
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FIG. 1. Rate of 55Fe uptake by Fe-starved cells of wild-type strain FA19 (OI), TF- mutant FA6367 (0), LF- mutant FA6353 (-), and [TF
LF]- mutant FA6303 (-). Uptake values represent the difference in amount of 55Fe internalized by energy-sufficient cells and energy-
poisoned (KCN-treated) cells. Each value represents the mean of two or more experiments + standard deviation.
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FIG. 3. Binding of [1251]TF (5 ,uM) by live Fe-starved cells of
FA19, in the presence of increasing concentrations of unlabeled
Fe-TF (0) or Apo TF (2). Values represent the mean of two
experiments performed in duplicate.
existence of a saturable, low-affinity, gonococcal TF recep-
tor, as suggested previously (11). The receptor appeared to
bind human TF specifically, but did not appear to be able to
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FIG. 5. Binding of TF-HRP to Fe-starved cells of wild-type
strain FA19; TF- mutants FA6338, FA6356, FA6342, FA6367, and
FA6366; LF- mutant FA6353; and [TF LF]- mutant FA6303.
Concentrations of TF-HRP (nanograms per milliliter) are shown
above each column.
y eucaryotes possess TF receptors, we con- TF mutants are deficient in TF-receptor function. In a dot
se receptors could be similar in structure to blot TF-binding assay (using ligand dilutions), TF- mutants
TF receptor. Antibodies against the human FA6338, FA6356, FA6342, FA6367, and FA6366 all were
receptors did not react in Western blots dramatically reduced in ability to bind TF-HRP as compared
vith Fe-starved gonococcal membranes or in with the wild type, parental strain FA19 (Fig. 5). These
)blots with Fe-starved whole gonococcal mutants were unaltered in ability to bind LF-HRP (Fig. 6). In
a cDNA clone of the human TF receptor a quantitative, equilibrium-phase binding assay with live
F. Ruddle, University of California at San cells, FA6366 was reduced significantly in its ability to bind
d to hybridize to gonococcal DNA under low [125I]TF as compared with the wild type (Fig. 2), suggesting
i not shown). that the differences in binding of the HRP conjugates to dried
was not characterized by the equilibrium- cells reflected physiologically important reduction in binding
nts because of excessive background due to of the ligand.
LF to the plastic microcentrifuge tubes. In quantitative, equilibrium-phase binding assays, Fe-
mutants and the parent strain by the solid- starved TF- strains bound similar amounts of [1251I]TF as
ggested that gonococci also possess an LF compared with Fe-sufficient FA19 cells (Fig. 2). One expla-
Ilow). nation of this phenomenon would be that Fe-starved TF
mutants are reduced in receptor number, perhaps due to a
deficient regulatory mechanism for the TF receptor. Alter-
native explanations are that the Fe-starved TF- mutants
bind less ligand due to the lower affinity of an altered TF
receptor or that there exists a second low-affinity or low-
copy-number receptor in which the mutants are not defec-
tive. Scatchard analysis of data from [251I]TF-binding exper-
iments, using Fe-starved FA19, did not reveal a second
receptor (data not shown). Iron regulation of receptor func-
tion was tested in the following experiment. In a dot blot
binding assay (using cell dilutions), Fe-starved mutant
e s....w w wFA6342 (TF-) bound TF approximately as well as Fe-
sufficient FA19 (Fig. 7), as above. However, Fe-starved cells
_ * of FA6342 were able to bind TF-HRP significantly better
than FA6342 cells which were grown under Fe-sufficient
conditions (Fig. 7). The relative upregulation in activity was
ig of TF-HRP (500 ng/ml) to Fe-starved cells of similar to the upregulation of receptor activity in FA19. This
rsence of decreasing concentrations of unlabeled experiment demonstrated that the mutant fully retains iron
iman ApoTF, mouse Fe-TF, or human LF (nano- regulation.
tr). LF- mutants are deficient in LF-receptor function. In dot
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FIG. 6. Binding of LF-HRP to Fe-starved cells of wild-type
strain FA19; TF- mutants FA6338, FA6356, FA6342, FA6367, and
FA6366; LF- mutant FA6353; and [TF LF]- mutant FA6303.
Concentrations of LF-HRP (nanograms per milliliter) are shown
above each column.
blot binding assays (with ligand dilutions), FA6353 (LF-)
consistently bound LF-HRP less well than FA19 (Fig. 6), but
was unaltered in ability to bind TF-HRP (Fig. 5). Strain
FA6246 (LF-) was similarly decreased in the ability to bind
LF (data not shown). Thus, the loss in the ability to acquire
LF-bound Fe was associated with the loss of a functional LF
receptor.
[TF LF]- mutants bind both TF and LF normally. FA6303
[TF LF]- demonstrated normal ability to bind both TF-HRP
and LF-HRP (Fig. 5 to 7). Since it was fully Fe regulatable
(Fig. 7), the defect in FA6303 was not an inability to regulate
expression of the receptor. The defect must be at some step
in the release or internalization of iron. Mutant FA6378 was
similarly able to bind both TF and LF (data not shown).
Thus, the loss in ability of the [TF LF]- mutants to inter-
nalize TF- and LF-bound Fe was not due to a deficiency in
either receptor function or regulation.
Cell dilution








FIG. 7. Binding of TF-HRP (500 mg/ml) to Fe-sufficient (+) and
Fe-starved (-) cells of wild-type strain FA19, TF- mutant FA6342,
and [TF LF]- mutant FA6303. Each column represents a onefold
cell dilution of the previous column.
DISCUSSION
Receptor-mediated acquisition of Fe from human TF and
LF has been suggested for several human specific patho-
gens, including the gonococcus (11, 23-25, 32, 33). We
further characterize the gonococcal TF and LF receptors
and provide substantial genetic and biochemical evidence for
the critical importance of the TF and LF receptors to Fe
acquisition from these sources.
The human Fe-binding glycoproteins TF and LF are very
similar in structure and affinity for Fe. Not surprisingly, the
mechanisms used by the gonococcus to scavenge Fe from
these sources share several characteristics, including the use
of receptors. However, the gonococcal TF and LF receptors
are distinct entities. Mutants blocked in TF receptor func-
tion retained wild-type ability to bind LF and vice versa.
Reciprocal transformations between TF- and LF- muta-
tions always produced an RI of 1.0 or greater, indicating
nonlinkage of the respective mutations and thus nonlinkage
of genes responsible for TF and LF receptor function. Point
mutations which simultaneously disrupted Fe acquisition
from both TF and LF did not affect receptor function and
were not linked to those mutations which did disrupt the
binding of TF or LF.
The calculated affinity of the gonococcal TF receptor is
quite low (Kd, 5 x 10-7 M) compared with the eucaryotic TF
receptor (Kd, 10-9 M) (34). However, the affinity of the
gonococcal receptor is very similar to that reported for the
meningococcal TF receptor (33). The gonococcal receptor
also resembles the meningococcal receptor (27, 33) in its
inability to discriminate effectively between Fe-TF and
apo-TF. This is also quite unlike the TF receptor of humans
which at physiological pH binds apo-TF at a much reduced
affinity compared with Fe-TF. For these reasons, it may
appear remarkable that the gonococcus is able to compete
effectively for essential Fe-TF in an environment in which
Fe-TF is bound more avidly and specifically by host cells.
However, the gonococcal TF receptor may not directly
compete with host TF receptors, since the concentration of
unbound TF in serum approaches 30 ,uM, far above the 1 puM
required to saturate binding to the gonococcus (14). The
relatively low affinity of the receptor for TF and saturation at
concentrations well below serum levels may also explain
why it is not necessary for the gonococcus to discriminate
between Apo-TF and Fe-TF: each TF molecule readily
dissociates from the gonococcal cell surface and is rapidly
replaced by another TF molecule.
The TF receptor appears to be essential to Fe scavenging
from TF. Point mutants which lost the wild-type ability to
bind TF were unable to internalize TF-bound Fe and conse-
quently were unable to grow when TF was the sole Fe
source. Similarly, point mutants which could not bind LF
were not able to utilize it as an Fe source. These results
suggest that receptor binding is a prerequisite to Fe scav-
enging from both TF and LF and further suggests that
receptor-independent pathways for Fe acquisition from
these sources do not exist.
It is not clear whether the trf and Irf mutations affect the
receptor genes, or whether these mutations disrupt the
function of the receptors by altering the framework in which
the receptors lie. The framework could include various outer
membrane proteins, lipopolysaccharides, or other mem-
brane components. Further work clearly is required to
determine whether trf and Irf mutations lie within the struc-
tural genes for the respective receptors.
The TF and LF utilization pathways appear to be linked
VOL. 172, 1990 5231
5232 BLANTON ET AL.
by the common use of at least one protein not involved in
receptor function. The [TF LF]- mutants simultaneously
lost the ability to utilize TF and LF, but retained the ability
to bind both of these proteins. These mutants retained the
ability to utilize all other Fe sources, suggesting that the
protein common to the TF and LF utilization pathways was
not required for Fe3" uptake from citrate or Fe2+ uptake
from heme compounds. The function altered by the tlu
mutations is unknown, but the tlu-encoded protein may be
required for releasing Fe from TF or LF bound to receptors
or for transport of Fe into the cells after release from TF or
LF. The specificity of tlu mutations for Fe uptake from TF or
LF clearly distinguishes them from the mutation isolated in
meningococcal strain FAM11, in that FAM11 was unable to
take up any form of Fe3` (6). The very close similarity of the
Fe-scavenging systems of gonococci and meningococci sug-
gests that this and presumably many other classes of gono-
coccal Fe utilization mutants remain to be discovered.
The recombination data from reciprocal crosses between
gonococcal Fe uptake mutants suggested the existence of
three linkage groups: one for trf mutations, a second for lf
mutations, and a third for tlu mutations. Within each group,
some mutations appeared to be very close on the genome
(RI, 0.05 to 0.10), whereas others appeared to be more
distant (RI, 0.4 to 0.6). Unfortunately, there are few data by
which to relate genetic distances to physical map distances
in the gonococcus. In an earlier report, recombination data
were related to physical sizes of transforming DNA for
certain linked gonococcal ribosomal genes; loci that exhib-
ited 10 to 20% cotransformation were estimated to be
separated by 10 to 15 kilobases (30). This suggests that
mutations that exhibit an RI of 0.5 may be separated by
several kilobases and conceivably could affect separate
proteins. If this were so, it would suggest that the TF or LF
receptors or both could be a complex of two or more
proteins. Much more evidence is required to understand the
physical proximity of these mutations and the nature of the
affected gene products.
The isolation and characterization of the TF-, LF-, and
[TF LF]- mutants have revealed that the disruption of a
small number of proteins can effectively prevent gonococci
from obtaining Fe from both TF and LF. If the ability to
utilize TF and LF is critical to pathogenesis, similar disrup-
tions caused by the binding of vaccine-directed antibodies
may prove effective in preventing gonococcal infections.
However, the importance of TF or LF utilization to gono-
coccal pathogenesis has not been clearly established. Al-
though LF- mutants have been isolated in vivo, it is not
clear how these gonococcal strains obtain essential Fe on
mucosal surfaces where LF is the dominant Fe source.
Leakage of serum TF or heme compounds to the mucosa,
especially in menstruating women, may provide sufficient
levels of Fe, whereas on rectal mucosa hydroxamate sider-
ophores may be present in sufficient quantities to provide
essential Fe (38). In contrast, the ability to utilize TF appears
to be critical, as no TF- mutant has ever been isolated in
vivo. Proof of the in vivo relevance of the TF and LF
Fe-scavenging system may be possible by using these mu-
tants in human challenge experiments.
APPENDIX
The data collected in transformation experiments were the num-
ber of CFU (Y) of N. gonorrhoeae that grew under various experi-
mental combinations: different donor strains, different growth media
selecting for LF+, TF+, and Rif, and different recipient strains (for
the reciprocal transformation experiment). The criterion of interest
was a ratio of ratios, adjusting the colony count of the donor-
recipient transformants in a test medium (LF+ or TF+) for the
reference media (Rif) and for the standard donor FA19-recipient
transformant colony count. This is called the recombination index
(RI). Comparisons of the mutant strain RIs were of interest.
Statistical inferences for the RIs were based on a multifactor
analysis of variance (ANOVA) (21). For such ANOVA methods, it
is generally assumed that the chance variables incorporated in the
usual statistical model (called the errors) have a closely normal
distribution (symmetric about 0). However, in the current case, Y
was a positive integer valued random variable, and it had presum-
ably a skewed distribution for which the usual normal approxima-
tion might not have been adequate. In practice, this drawback is
often eliminated by the use of a transformation Y - Y* = a
monotone function of Y. For count data, one may take Y* = log1oY
or even YA, for some X > 0; the choice of A = 1/2 is very common.
Towards this objective, we adopted the following transformation:
Y* = log1o(colony count) = log10 Y. For this transformed variate Y*,
the assumed ANOVA model actually related to a multifactor mul-
tiplicative model for the Y, with the Y's being all non-negative.
However, the Y* are not restricted to be non-negative, and this
simplifies the statistical analyses. For this log-dependent variate
model, the errors were likely to be more symmetrically distributed
(than for the multiplicative model), and moreover, logl0(count) used
in the analysis resulted in reduced variation among the counts and
simplified RI comparisons (the difference of log values is equivalent
to standard ratios). Explanatory variables were donor strain type,
medium type, day effect, and the interaction between strain and
medium. The reciprocal transformation experiment had a more
complex data structure due to different recipient strains, so the
model corresponding to it was expanded to account for this source
of variation and the strain-medium interaction within it (see below).
The RI comparisons of interest were tested by using ANOVA
contrasts of one or more linear combinations of the strain-medium
interaction effects, which represent the across-strain variation of
RIs. For the reciprocal transformation experiment, an additional
analysis objective was the fitting of another statistical model which
described the pattern of variation among the strain-medium interac-
tion estimates of log10(RI) through a "map." Thus, the experiment
had a two-stage analysis - an overall analysis with a model for all
sources of variation and embodied in it a model for the strain-
medium interaction terms, which ultimately was interpreted as a
map of the mutation sites.
Mapping the mutational sites. The purpose of statistical analysis in
this experiment was to determine whether the RIs of the mutant
strains displayed in Table 2 were statistically different from the
standard FA19 (RI, 1.0 by definition) and from each other. An
ANOVA model was fit with logl0(colony count) as the dependent
variable and strain type, medium type, their interaction, and day
effect as explanatory variables. The day effect was found to be
nonsignificant, and day was therefore removed from the model.
Thus, the ANOVA model for the evaluation of RI was as follows:
logl0(counts) = strain + media + strain*media. The F-test for the
interaction was highly significant (P < 0.001), which implied that
some of the RIs might be significantly different from 1.0 and
individually contrasted with FA19 LF+ and TF+ through F-tests for
corresponding linear combinations of interaction effects. The RI for
FA1012 LF+ was found to be significantly different from that for
FA19 LF+ (P = 0.001), and FA6342 TF+ was found significantly
different from FA19 TF+ (P = 0.004). Additional linear combina-
tions of interaction effects were constructed for F-tests contrasting
the LF+ and TF+ RIs of each mutant strain to one another. A
significant difference was found for FA1012 and FA6342 (P = 0.001
and 0.002, respectively). The mutant strains were then compared
with each other considering both TF+ and LF+ RIs. All three
mutant strains were found to be statistically different from each
other (P < 0.001). It could be concluded that the RI of FA1012 for
LF+ and the RI of FA6342 for TF+ were each significantly smaller
than 1.0, but there was essentially no difference between FA6378
and FA19 for either LF+ or TF+.
LF- mutations are linked. Comparisons among the RIs for LF-
mutations displayed in Table 5 were analyzed in a similar manner as
described above. The ANOVA model of log1o(colony count) in-
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TABLE Al. Mutation map model structure'
Recipient Donor strain
strain FA6338 FA6342 FA6356 FA6366 FA6367
FA6338 A A+B A+B+C A+B+C+D
FA6342 A A+B+E A+B+C+E A+B+C+D+E
FA6356 A+B A+B+E A+2B+C+E A+2B+C+D+E
FA6366 A+B+C A+B+C+E A+2B+C+E A+2B+2C+D+E
FA6367 A+B+C+D A+B+C+D+E A+2B+C+D+E A+2B+2C+D+E
a A, A reference value; B, log(FA6356 RI) - log(FA6342 RI); C, log(FA6366 RI) - log(FA6356 RI); D, log (FA6367 RI) - log(FA6366 RI); E, log(FA6342 RI)
- log(FA6338RI), where the RIs are of the named recipients for all donors, or equally the named donors for all recipients.
cluded the following explanatory variables: day effects (which were
significant with P < 0.01), strain type, medium type, and strain-
medium interaction. The interaction was significant (P < 0.001),
indicating that some of the RIs might be different from 1.0, and
further analyses were appropriate. F-tests for contrasts among
linear combinations of interaction effects found the RIs for all strains
except FA6246 significantly different from that for FA19 (P <
0.001). Additional F-tests suggested that FA6246 was similar to
FA19 (P = 0.106) and was different from all other mutant strains in
Table 5 (0.002 < P < 0.028). It could be concluded that all mutant
strains except FA6246 had RIs significantly smaller than 1.0.
TF- mutation sites are mapped. The objective of this experiment
was to compare the RIs in Table 3 and use them to form a relational
map of the mutant strains. This analysis was more complex due to
the reciprocal nature of the transformations. Each strain was both a
donor and a recipient, so the following effects were included in the
ANOVA model of log1o(colony counts) as explanatory variables:
recipient, donor within recipient, day within recipient, medium
type, the interaction of recipient and medium type, and the interac-
tion of donor and medium type within a recipient. The ANOVA
model is as follows: log1o(counts) = recipient + donor(recipient) +
day(recipient) + medium + recipient*medium + donor*medium
(recipient). All effects were significant at P < 0.001. The significant
donor-medium within recipient interaction suggested that some of
the corresponding RIs might be different from one another, and
further analyses were appropriate. F-tests for contrasts among
linear combinations of interaction effects found significant RI differ-
ences among all donor RIs for each recipient separately and for all
recipients simultaneously (P c 0.001). This implies that at least
some strains, when in the role of donor, are significantly different
from other donors, both when examining one recipient and taking all
recipients into account.
The objective of further analysis was to construct a model which
described the variation among the log1o(RI) in terms of a map of
mutation sites. This model had three features which were applied in
three corresponding steps. These features were symmetry of the RI
in Table 3 relative to the main diagonal, additivity of recipient and
donor components, and equality of recipient and donor components.
The structure imposed by the model is displayed in Table Al.
F-tests for corresponding linear combinations of donor*medium
within recipient interaction effects were applied to test each of the
three steps leading to this map model. Although the results of these
tests indicated significant lack of fit (P < 0.001), the model was
nevertheless considered descriptively reasonable because it ex-
plained about 65% of the variation among all the log1o(RI).
TABLE A2. Estimates of average RIs and (in parentheses) 95% confidence
intervals for average RIs based on the reciprocal transformation
map model
Mutant Mutant strain
strain FA6338 FA6342 FA6356 FA6366 FA6367
FA6338 0.16 0.07 0.35 0.24
FA6342 (0.11,0.22) 0.05 0.25 0.17
FA6356 (0.05,0.10) (0.03, 0.07) 0.11 0.08
FA6366 (0.25,0.49) (0.18,0.35) (0.08, 0.16) 0.39
FA6367 (0.17,0.34) (0.12, 0.25) (0.05, 0.11) (0.27, 0.55)
As displayed in Table Al, the imposed model had five parameters
(A through E) for characterizing the variation among RIs. Estimates
of these parameters were determined by multiple linear regression
methods. "Dummy" variables which represented the map structure
parameters were defined, and then the following ANOVA model
was fit: loglo(colony count) = recipient + donor(recipient) +
day(recipient) + medium + recipient*medium + 5 map structure
parameters. Predicted values (which take into account all effects in
the above ANOVA model) for the RIs were expressed as antiloga-
rithms of linear combinations of the five estimated model parameters
(as displayed in Table Al). These estimates and their 95% confi-
dence intervals are displayed in Table A2.
The final step to defining the map was the estimation of distance
ratios between each pair of mutant strains. The distance ratio
reflects the property that the ratio of predicted RI for any pair of
donors is the same for all recipients (and is also the same as the
ratio of predicted RI for the corresponding pair of recipients for
all donors). The numbers 10B, 10C, 10D, and 10E correspond to ratios
of (FA6356RI)/(FA6342RI), (FA6366RI)/(FA6356RI), (FA6367RI)/
(FA6366RI), and (FA6342RI)/(FA6338RI), respectively. Ratios of
all other RI/RI combinations were similarly defined, for example,
(FA6356RI)/(FA6338RI) = 10B+E, corresponding to log(FA6356RI)
- log(FA6338RI) = B+E for any fixed recipient (or donor) in Table
Al. Distance ratios and their 95% confidence intervals were esti-
mated in a similar manner as the predicted RI values. All ratios were
found to be significantly different from 1.0 except for that corre-
sponding to FA6367RI/FA6338RI. The distance ratios for the im-
posed model and their reciprocals are shown in Table A3. Their
interpretation through multiplication of adjacent distance ratios
suggests a map with the pattern
FA6356 FA6342 FA6338 FA6367 FA6366
"Very"
Far Close Close Close
The distance ratios in Table A3 represent how often one donor
strain recombined compared with another donor strain regardless of
recipient (or vice versa) standardized by Rif and FA19. The FA19
part of each ratio cancels, and the distance ratio for any fixed
recipient is equivalent to (donor 1 TF/Rif)/(donor 2 TF/Rif). Since
the recombination information was collected as ratios of recombi-
nants for different strains, the resulting map is then interpreted by
TABLE A3. Reciprocal transformation map estimates of row/column
distance ratiosa
DNA Row/column distance ratio for given DNA strain
strain FA6356 FA6342 FA6338 FA6367 FA6366
FA6356 0.43 0.31 0.28 0.20
FA6342 2.31 0.72 0.66 0.45
FA6338 3.23 1.40 0.92 0.63
FA6367 3.52 1.52 1.09 0.69
FA6366 5.13 2.22 1.59 1.46
a e.g., FA6356 RI is 0.43 times FA6342 RI regardless of recipient. All
distance ratios are significant at the P = 0.05 level except the FA6338/FA6367
ratio of 1.09 (reciprocal = 0.92).
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using multiplicative ratios whose reference value of no recombina-
tion between numerator and denominator is 1.0. This is in contrast
to the more common recombination fraction (number of recombi-
nants divided by the total number of matings for a particular donor
and recipient) which results in a map of additive fractions whose
reference value of no recombination between donor and recipient is
zero.
We have previously commented on the three features which were
applied in three corresponding steps to obtain Table A3. Also, we
have noticed a significant lack of fit of the proposed model. Being
aware of this lack of fit, we might consider an alternative (multipli-
cative) model with Y* = (count)' = YX, for some X > 0. A best-fitting
model could have been chosen by estimating k from the data.
However, the complexity of the statistical analyses would have
increased enormously, and formulation of conclusions would not
have been straightforward (with such a data-oriented version of A).
Thus, we prefer not to pursue such complexity. Larger data sets
would enable further evaluation of statistical conclusions.
Further details on this analysis are available by request to the
authors (S.M.D., G.G.K., and P.K.S.).
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